| Autor: |
Afzali, Shima, Mohammadisoleimani, Elham, Mansoori, Yaser, Mohaghegh, Poopak, Bahmanyar, Maryam, Mansoori, Behnam, Pezeshki, Babak, Nikfar, Ghasem, Tavassoli, Alireza, Shahi, Abbas, Moravej, Ali |
| Předmět: |
|
| Zdroj: |
Inflammation Research; Jul2023, Vol. 72 Issue 7, p1513-1524, 12p |
| Abstrakt: |
Background: Oral lichen planus (OLP) is a T cell-mediated chronic autoimmune disease, whose pathogenesis and etiology are not entirely understood. OLP is characterized by subepithelial lymphocyte infiltration and elevated intra-epithelial lymphocytes. The majority of lamina propria lymphocytes are CD4+ T cells. CD4+ helper T (Th) cells play a crucial role in activating CD8+ cytotoxic T cells (CTLs) through interactions and cytokine production. Th1 and Th2 cells are well-accepted to be associated with OLP pathogenesis. However, OLP treatment is challenging yet, the more information we have about the pathology of OLP, the easier it will be treated. With the discovery of Th17 cells in recent years and the demonstration of their role in autoimmune disease, many researchers started to investigate the role of Th17 in the pathogenesis of OLP. Methods: To make up this review, studies covering the role of TH17 in different types of lichen planus were selected from major databases. Results: As we review in this article, Th17 cells and their signature cytokines play an important role in OLP pathogenesis. As well, utilizing some anti-IL-17 antibodies showed promising results in improving the disease; however, more studies are still needed to better understand and treat OLP. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink